Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies that specifically bind to and inhibit human synovial phospholipase A.sub.2 type A

Antibodies that specifically bind to and inhibit human synovial phospholipase A.sub.2 type A

US Patent 5552530 · Granted Sep 3, 1996

Estimated economic value: $12,735,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulation2022
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2015
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2014
Use of platelet activating factor acetylhydrolase as a biomarker for anaphylaxis2013
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the t2013
Methods for treating diarrhea-associated irritable bowel syndrome2012
Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis2012
Methods of screening for compounds that modulate the activity of ADEC, a chemoki2011
Methods of treatment with anitbodies to a chemokine expressed in inflamed adenoi2010
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2009
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives2008
Antibodies to a chemokine expressed in inflamed adenoid2007